Triorganotin(IV) pyrazolinates of the type R3Sn(C15H12N2O · X) [where C15H12N2O · X = 3(2′-hydroxyphenyl)-5(4-X-phenyl)pyrazoline {where X = H (a); CH3 (b); OCH3 (c); Cl (d) and R = Me, Pr n and Ph}] have been synthesized by the reaction of R3SnCl with the sodium salt of pyrazolines in a 1 : 1 molar ratio, in anhydrous benzene. These newly synthesized derivatives have been characterized by elemental analysis (C, H, N, Cl and Sn), molecular weight measurement as well as spectral studies [IR and multinuclear NMR (1H, 13C and 119Sn)]. The bidentate behaviour of the ligands was confirmed by IR, 1H and 13C NMR spectral data. Trigonal bipyramidal structure around tin(IV) atom for R3Sn(C15H12N2O · X) has been suggested. The free pyrazoline and a few triorganotin(IV) pyrazolinates have also been screened for their antibacterial and antifungal activities. Some triorganotin(IV) pyrazolinates exhibit higher antibacterial and antifungal effects than free pyrazoline and some of the antibiotics.
No takes yet. Share an insight, caveat, or question.
Tripathi et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: